Stonepine Capital Management, LLC Celcuity Inc. Transaction History

Stonepine Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$5.35 - $10.11 $1.28 Million - $2.42 Million	-239,433 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$11.96 - $19.35 $660,897 - $1.07 Million	-55,259 Reduced 18.75%	239,433 $3.16 Million
Q3 2021 Nov 12, 2021	BUY	$17.35 - $24.87 $1.31 Million - $1.88 Million	75,741 Added 34.59%	294,692 $5.3 Million
Q2 2021 Aug 16, 2021	BUY	$14.25 - $30.93 $1.57 Million - $3.4 Million	109,870 Added 100.72%	218,951 $5.26 Million
Q1 2021 May 14, 2021	BUY	$10.43 - $17.8 $1.14 Million - $1.94 Million	109,081 New	109,081 $1.56 Million

107

30.3M

30.8K

152K

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $187M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.